The WHO pointers stipulate that manufacturers have to acquire and adhere to specific upkeep schedules based upon products specifications and utilization styles. Manufacturers planning to apply these procedures need to give robust validation knowledge to demonstrate their equivalence to pharmacopoeial procedures. As these new systems emerg